BMYMP
Bristol-Myers Squibb Company PFD CONV 2
Save
99.29B
Market cap
3555.56x
Current P/E
–
Forward P/E
About
Health care
Sector
Drug Manufacturers - General
Industry
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.
Similar securities
Based on sector and market capitalization
Report issue